PPD’s Singapore Lab Earns CAP Accreditation

PPD’s global central lab operations in Singapore has earned accreditation by the College of American Pathologists (CAP), validating its ability to deliver high-quality, reliable data that meet excellence standards designed to enhance patient safety and speed drug development.

The Singapore facility is the company’s fourth central lab to achieve this accreditation. This program is internationally recognized and uses rigorous accreditation standards. A team of lab professionals inspected the facility, examined staff qualifications, lab equipment and facilities, safety programs and records, as well as overall management of lab operations.

“Achieving CAP accreditation six weeks after opening our Singapore facility demonstrates the expertise of our scientists and our commitment to excellence,” said Steve Lobel, Ph.D., vice president of PPD’s global central laboratory operations. “Within weeks of opening our laboratory, we added new assay technologies and are supporting high-level testing to expand upon the services we offer our clients.”